Latest News about NVCR
Recent news which mentions NVCR
From Benzinga
 
   3 Stocks That Could Help You Retire a Millionaire
   
  
  
  June 13, 2022
  From Motley Fool
 
   3 Stocks Down 50% or More That You Can Buy Right Now
   
  
  
  June 11, 2022
  From Motley Fool
 From Motley Fool
 From Benzinga
 From Benzinga
 From Motley Fool
 From Motley Fool
 From Benzinga
 From Motley Fool
 From Motley Fool
 
   2 Under-the-Radar Biotech Stocks to Buy in 2022
   
  
  
  April 11, 2022
  From Motley Fool
 
   3 Growth Stocks to Buy With $1,000 Right Now
   
  
  
  April 08, 2022
  From Motley Fool
 
   3 Biotech Stocks to Buy in April
   
  
  
  April 03, 2022
  From Motley Fool
 
   Novocure's TTFields Show Improved Progression-Free, Overall Survival Over Matched-Control
   
  March 25, 2022
  Tickers 
   NVCR
  
  
  From Benzinga
 
   The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
   
  
  
  March 25, 2022
  From Benzinga
 Tickers 
   NVCR
  
  
  From Motley Fool
 From Motley Fool
 From Motley Fool
 
   Novocure Q4 Earnings Miss Street View, New Data Shows TTFields Initiates Downstream Anti-Tumor Response
   
  February 24, 2022
  Tickers 
   NVCR
  
  
  From Benzinga
 
   3 Stocks With Lower Market Caps Than Shiba Inu to Buy Right Now
   
  
  
  February 20, 2022
  From Motley Fool
 
   Scared of the Bear? Buy These 3 Healthcare Stocks
   
  
  
  February 18, 2022
  From Motley Fool
 
   Bionano Stock Looks to Have a Monster Comeback in Its Future
   
  
  
  February 17, 2022
  From InvestorPlace
 
   12 Health Care Stocks Moving In Wednesday's After-Market Session
   
  
  
  February 09, 2022
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 


